Literature DB >> 11438059

Theoretical investigation of the role of choriocapillaris blood flow in treatment of subfoveal choroidal neovascularization associated with age-related macular degeneration.

R W Flower1, C von Kerczek, L Zhu, A Ernest, C Eggleton, L D Topoleski.   

Abstract

PURPOSE: To investigate the relationship between choriocapillaris blood flow and blood flow through an overlying choroidal neovascularization, as it relates to photocoagulation-induced changes in the choriocapillaris circulation.
METHODS: A theoretical model that simulates the blood flow in the choriocapillaris and choroidal neovascularization of the human eye was developed, based on histologically determined vascular geometry and experimentally measured blood pressure gradients. The choriocapillaris blood pressure and blood flow were examined before and after simulated photocoagulation of various Sattler layer vessels entering the choriocapillaris in the vicinity of the choroidal neovascularization. (The Sattler layer is the inner layer of medium-sized choroidal vessels that includes both arterioles and venules that supply the choriocapillaris.)
RESULTS: The theoretical model showed that both partial and complete occlusion of either Sattler arteriole or venous vessels in the vicinity of the capillary-like vessels connecting a choroidal neovascularization to the underlying choriocapillaris results in significant choroidal neovascularization blood flow reduction. These theoretical results are similar to clinically observed changes induced by laser photocoagulation of feeder vessels. (In this discussion, the term "feeder vessels" refers to those vessels in an indocyanine green angiogram image that appear to supply blood to a choroidal neovascularization; these vessels appear to be Sattler layer vessels, rather than the histologically demonstrated short, capillary-like vessels that form choriocapillaris-choroidal neovascularization communications.)
CONCLUSIONS: Reduction of choriocapillaris blood flow underlying a choroidal neovascularization may be sufficient to reduce the blood flow rate in the choroidal neovascularization and thereby reduce the associated retinal edema. The results also suggest that reduction of choriocapillaris blood flow may be the common hemodynamic event associated with the successful application of several currently practiced methods of choroidal neovascularization treatment, including feeder vessel photocoagulation, photodynamic therapy, transpupillary thermotherapy, and prophylactic drusen photocoagulation. Ultimately, this model may be useful in determining optimal placement of laser photocoagulation burns to achieve a desirable perturbation in choroidal blood flow distribution and thereby reduce choroidal neovascularization blood flow to the extent necessary to obliterate associated retinal edema.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11438059     DOI: 10.1016/s0002-9394(01)00872-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  24 in total

1.  Ultrahigh-Speed, Swept-Source Optical Coherence Tomography Angiography in Nonexudative Age-Related Macular Degeneration with Geographic Atrophy.

Authors:  WooJhon Choi; Eric M Moult; Nadia K Waheed; Mehreen Adhi; ByungKun Lee; Chen D Lu; Talisa E de Carlo; Vijaysekhar Jayaraman; Philip J Rosenfeld; Jay S Duker; James G Fujimoto
Journal:  Ophthalmology       Date:  2015-10-17       Impact factor: 12.079

2.  Effects of photodynamic therapy with verteporfin for the treatment of chronic central serous chorioretinopathy: An uncontrolled, open-label, observational study.

Authors:  Yildirim Bayezit Sakalar; Ugur Keklikci; Kaan Unlu; Mehmet Fuat Alakus; Ismail Hamdi Kara
Journal:  Curr Ther Res Clin Exp       Date:  2010-06

3.  Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.

Authors:  Wai-Man Chan; Timothy Y Y Lai; Amy L Wong; David T L Liu; Dennis S C Lam
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

4.  In vitro and computational modelling of drug delivery across the outer blood-retinal barrier.

Authors:  Alys E Davies; Rachel L Williams; Gaia Lugano; Serban R Pop; Victoria R Kearns
Journal:  Interface Focus       Date:  2020-02-14       Impact factor: 3.906

5.  Phase I clinical trial results of verteporfin enhanced feeder vessel therapy in subfoveal choroidal neovascularisation in age related macular degeneration.

Authors:  I Kozak; L Cheng; D E Cochran; W R Freeman
Journal:  Br J Ophthalmol       Date:  2006-06-14       Impact factor: 4.638

6.  [Transpupillary thermotherapy for occult choroidal neovascularizations].

Authors:  U Weber; H Hecker
Journal:  Ophthalmologe       Date:  2005-04       Impact factor: 1.059

7.  Roughened silver electrodes for use in metal-enhanced fluorescence.

Authors:  Chris D Geddes; Alexandr Parfenov; David Roll; Ignacy Gryczynski; Joanna Malicka; Joseph R Lakowicz
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2004-07       Impact factor: 4.098

8.  Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration.

Authors:  Mamdouh M Kabeel; Ashraf M El-Batarny; Mohamed K Tameesh; Moustafa A Abou El Enein
Journal:  Clin Ophthalmol       Date:  2008-03

9.  Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy.

Authors:  F Gelisken; B A Lafaut; W Inhoffen; M Voelker; S Grisanti; K U Bartz-Schmidt
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

10.  Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy.

Authors:  Aya Iriyama; Ryo Obata; Yuji Inoue; Hidenori Takahashi; Yasuhiro Tamaki; Yasuo Yanagi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-09-06       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.